---

Background and Objective: Esophageal and gastric cancers are among the most common and fatal cancers. These are diagnosed at the latest phase and the prognosis is too poor. Due to the importance and high incidence rate of the upper gastrointestinal cancers in Golestan province, this study was conducted to explore the overall survival rate of these patients in rural area of this region. Materials and Methods: In this descriptive cross-sectional study, a total of 121 pathologically confirmed esophageal or gastric cancers, with rural place of residence, were retrieved from the cancer registry at the health department in Gorgan. After conducting interview with patients or their relatives, analysis of their sociodemographic and clinicopathologic features was performed. The median survival rate was compared regarding age groups and gender using Kaplan-Meier statistical test. Results: Male to female ratio in esophageal and gastric group were 1.2 to 1 and 3.8 to 1, respectively. Short-term survival rates were 54.76% and 26.2% for esophageal cancer and 66.6% and 37.5% for gastric cancer. Collected information regarding patients’ sociodemographic and clinicophathologic factors did not have significant association with patients’ survival in both esophageal and gastric cancers. The mean survival rate in patient with gastric and esophageal cancers according to age and gender was not significant. Conclusion: This study showed that the overall short-term survival rates for upper gastrointestinal cancers are very low in Golestan province. Therefore the need for intervention the need and allocating more diagnosis and therapeutic resources for upper gastrointestinal cancers are required.

---

Background and Objective: Ovarian cancer, also known as “The Silent Killer,” is one of the most dangerous cancers for women, which often diagnosed late and incurable. On the other hand, conventional therapies currently have limitations, failures and various side effects. This study was performed to determine the effect of pomegranate peel extract on the expression of angiogenesis stimulating gene (Vascular Endothelial Growth Factor: VEGF) by culturing A2780 cell line of ovarian cancer.
Methods: In this descriptive-analytical study, pomegranate peel extract was prepared and then ovarian cancer cells (A2780 cell line) were exposed to different concentrations of pomegranate peel extract (500, 250, 100, 75, 50, 25 and 10 µg/ml) for 48, 24 and 72 hours. Also, the survival rate of the cells was tested by MTT assay and VEGF gene expression was evaluated using RT-PCR.
Results: Pomegranate peel extract concentration of 500 µg/ml reduced the survival rate to 18% in 72 hours (P<0.05). At concentrations of 200, 100 and 50 µg/ml of pomegranate peel extract, the expression of VEGF reduced by 7%, 16% and 19%, respectively, which was significant compared to the control group (P<0.05).
Conclusion: Pomegranate peel extract, due to its numerous compounds and significant antioxidant properties, is likely to reduce metastasis and malignant manifestations by reducing the expression of the angiogenesis agent.